Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Paediatric Consumer Health in

Paediatric Consumer Health in Spain

19 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Spanish healthcare system to limit growth

Paediatric consumer health recorded a similar performance in 2018 to the previous year. Performance is strongly influenced by the Spanish healthcare system, which allows the same active ingredient in both reimbursable and non-reimbursable products, which reduces the potential of paediatric consumer health.

Shrinking consumer base

In 2018, Spain recorded the lowest birth rate in 40 years. No major rise in the birth rate is expected unless Spanish authorities take a more active role in promoting an increase.

The same categories support growth

In 2018, cough, cold and allergy remedies and also analgesics were the two categories supporting growth of paediatric consumer health. As with adult products, the higher level of prevalence of the flu for a longer period supported sales of both categories.

New ailments to support sales

As is happening in other developed countries, children in Spain are set to suffer from new aliments due to their somewhat unhealthy lifestyles. Spanish children spend too many hours playing with technology devices and take part in little sport or playing outside.

COMPETITIVE LANDSCAPE

In the hands of a few

As earlier in the review period, paediatric consumer health continued to be led in 2018 by the brand Dalsy. This paediatric ibuprofen accounted for over a fifth of category value sales; however, its value share declined in 2018 and this was linked to a shortage of supply, which was so important that explanations were given by Mylan on the national news.

OTC dermatological sales are strong

Mylan was followed by Johnson & Johnson in second and Reckitt Benckiser España in third in 2018. These two companies’ strengths lie within dermatological products.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

Delivery

Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Paediatric Consumer Health industry in Spain with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Paediatric Consumer Health industry in Spain, our research will save you time and money while empowering you to make informed, profitable decisions.

The Paediatric Consumer Health in Spain market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Paediatric Consumer Health in Spain?
What are the major brands in Spain?
What are the most popular formats for treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport:

Consumer Health market research database

Want to find out more about this report?

Request more information

Paediatric Consumer Health in Spain - Category analysis

HEADLINES

PROSPECTS

Spanish healthcare system to limit growth

Shrinking consumer base

The same categories support growth

New ailments to support sales

COMPETITIVE LANDSCAPE

In the hands of a few

OTC dermatological sales are strong

CATEGORY DATA

Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Consumer Health in Spain - Industry Overview

EXECUTIVE SUMMARY

Reasonable growth, but below expectations

Health is the new wealth

Johnson & Johnson continues to lead consumer health

Sales of OTC medicines fail to take off online

Spanish regulation continues to limit sales

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Paediatric Consumer Health in Spain

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Spanish healthcare system to limit growth

Shrinking consumer base

The same categories support growth

New ailments to support sales

COMPETITIVE LANDSCAPE

In the hands of a few

OTC dermatological sales are strong

Overview

Why buy this report?

SAMPLES

Delivery

Overview

Why buy this report?

Want to find out more about this report?

Table of Contents

Paediatric Consumer Health in Spain - Category analysis

HEADLINES

PROSPECTS

Spanish healthcare system to limit growth

Shrinking consumer base

The same categories support growth

New ailments to support sales

COMPETITIVE LANDSCAPE

In the hands of a few

OTC dermatological sales are strong

CATEGORY DATA

Consumer Health in Spain - Industry Overview

EXECUTIVE SUMMARY

Reasonable growth, but below expectations

Health is the new wealth

Johnson & Johnson continues to lead consumer health

Sales of OTC medicines fail to take off online

Spanish regulation continues to limit sales

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements: registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Company Reports

Recently Viewed

Complete Catalogue

Country Reports

Company Reports